Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic ...

Bristol Myers Squibb said it will acquire its struggling CAR-T partner 2Seventy Bio for $286 million, or $102 million net of ...

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.

A very bullish analyst move was the news generally responsible for Summit Therapeutics' (NASDAQ: SMMT) healthy mid-week stock price pop. The person behind the news was Evercore ISI pundit Cory Kasimov ...

The American public lacks transparency regarding the origin of their medications, and the assumption that their drugs come ...

In a notification issued on Sunday, the NBR said it had slashed the tax at source on the import of ingredients for oncology ...

An experimental breast cancer treatment co-developed by Pfizer and Arvinas significantly improved the time some patients ...

Pfizer (NYSE:PFE) stock and Arvinas (NASDAQ:ARVN) stock slip in reaction to mixed Phase 3 data for their breast cancer drug ...

New Delhi: Cancer patients facing prohibitive treatment costs in India can hope for relief: the nation's top drugmakers have ...

Jazz Pharmaceuticals acquires Chimerix (CMRX) for $935M, adding ONC201, a promising brain cancer drug. Find out why I believe ...